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Altered extrahepatic bile ducts, gut, and cardiovascular anomalies constitute the variable
phenotype of biliary atresia (BA).
Methods
To identify potential susceptibility loci, Caucasian children, normal (controls) and with BA
(cases) at two US centers were compared at >550000 SNP loci. Systems biology analysis
was carried out on the data. In order to validate a key gene identified in the analysis, biliary
morphogenesis was evaluated in 2-5-day post-fertilization zebrafish embryos after morpho-
lino-antisense oligonucleotide knockdown of the candidate gene ADP ribosylation factor-6
(ARF6, Mo-arf6).
Results
Among 39 and 24 cases at centers 1 and 2, respectively, and 1907 controls, which clustered
together on principal component analysis, the SNPs rs3126184 and rs10140366 in a 3’
flanking enhancer region for ARF6 demonstrated higher minor allele frequencies (MAF) in
each cohort, and 63 combined cases, compared with controls (0.286 vs. 0.131, P = 5.94x10-
7, OR 2.66; 0.286 vs. 0.13, P = 5.57x10-7, OR 2.66). Significance was enhanced in 77 total
cases, which included 14 additional BA genotyped at rs3126184 only (p = 1.58x10-2, OR =
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2.66). Pathway analysis of the 1000 top-ranked SNPs in CHP cases revealed enrichment of
genes for EGF regulators (p<1 x10-7), ERK/MAPK and CREB canonical pathways (p<1
x10-34), and functional networks for cellular development and proliferation (p<1 x10-45), fur-
ther supporting the role of EGFR-ARF6 signaling in BA. In zebrafish embryos, Mo-arf6 injec-
tion resulted in a sparse intrahepatic biliary network, several biliary epithelial cell defects,
and poor bile excretion to the gall bladder compared with uninjected embryos. Biliary defects
were reproduced with the EGFR-blocker AG1478 alone or with Mo-arf6 at lower doses of
each agent and rescued with arf6mRNA.
Conclusions
The BA-associated SNPs identify a chromosome 14q21.3 susceptibility locus encompass-
ing the ARF6 gene. arf6 knockdown in zebrafish implicates early biliary dysgenesis as a
basis for BA, and also suggests a role for EGFR signaling in BA pathogenesis.
Introduction
Biliary atresia (BA), which is characterized by jaundice and loss of extrahepatic bile ducts
(EHBD) at birth, affects 1:18000 Caucasian children and is fatal without surgical intervention
[1]. The BA disease phenotype is broad and understanding the molecular and developmental
basis of BA can improve diagnosis and selection of treatment. This task poses significant chal-
lenges, because BA presents shortly after birth suggesting an origin early during fetal develop-
ment in the embryologic type of BA, or perinatally in the isolated, potentially infectious/
inflammatory type of BA. Either type precludes the elucidation of conclusive evidence. This
evidence would ideally document disease progression in sequential fetal tissue. Phenotypic het-
erogeneity consisting of several associated extrahepatic anomalies further defies either a unified
mechanistic hypothesis or a perfect experimental model, but suggests that multiple susceptibil-
ity loci may be involved. Extrahepatic manifestations can include gut or cardiovascular anoma-
lies including laterality defects such as asplenia/polyspenia and heterotaxy to varying degrees
[2,3]. Disease complexity is compounded further by histological features which can overlap
with those of other cholestatic conditions such as neonatal cholestasis, ductal plate malforma-
tion, and Caroli’s disease [2,4,5]. A common pathophysiologic finding is failure to excrete bile
from the liver on nuclear imaging, mandating surgical drainage with portoenterostomy. This
procedure fails in nearly half of all patients leading to bile stasis and cirrhosis. As a result, BA
accounts for over a third of all pediatric liver transplants, worldwide [6]. Poorly developed
intrahepatic bile ducts can also explain failure of portoenterostomy. Such a lesion cannot be
identified with certainty amidst histological sequelae of biliary obstruction in most cases. These
features include reactive intrahepatic bile duct proliferation, cholestasis, fibrosis and cirrhosis,
which can distort liver architecture beyond recognition [7].
The role of environmental factors is underscored by the association of BA with rotavirus,
reovirus, and cytomegalovirus infections, and the fact that these viruses induce comparable
lesions experimentally. However, these models do not provide insight into the developmental
basis of BA suggested by the presence of ‘minor’ extrahepatic anomalies even in the isolated
variety of BA [8,9,10,11].
Toward generating novel unbiased hypotheses with evidence from diseased human subjects,
two sets of genome-wide association studies (GWAS) have provided new directions. In two
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North American children with BA, Leyva-Vega et al. [12] observed a common 1.76 heterozy-
gous deletion in chromosome 2q37.3. The deletion was inherited from the father who did not
have any liver disease in one of the two affected children, confirming that other loci and/or
environmental factors were also necessary in BA pathogenesis. These findings were confirmed
by Cui et al. in 6 of 61 children with BA from the same investigator group, in whom the dele-
tion was confined to the GPC1 gene within the same locus [13]. A novel developmental model
was used to generate supportive evidence, which consisted of impaired biliary network devel-
opment after gpc1 knockdown with morpholino antisense oligonuleotide (MO) in zebrafish
embryos. In 339 Chinese children with BA, Cheng et al. [14] confirmed the association between
BA and an intergenic chromosome 10q24 SNP locus, rs17095355, which had been reported
previously by Garcia-Barcelo et al. [15] from the same group. This SNP locus indicated the
involvement of the neighboring ADD3 gene in BA, because of differential immunostaining of
the ADD3 protein when diseased and normal liver tissue was compared. Recently, Tsai et al.
[16] also found an association between BA and one of 333 SNPs in the chromosome 10q24
locus in 171 North American BA patients. However, the best associated SNP, rs7099604, was
located in the first intron of ADD3 in this locus. Interestingly, knockdown of add3 in zebrafish
also impaired biliary network formation providing supportive evidence for yet another candi-
date gene identified with GWAS.
Together, these observations reinforce the idea that multiple susceptibility loci along with
environmental factors may be involved in BA, and suggest that replicating a GWAS finding
may be challenging. Adding to this difficulty is the fact that the SNPs best associated with BA
were located in different regions in the chromosome 10q24 susceptibility locus in Chinese and
North American patients. Finally, unrecognized minor extrahepatic anomalies, which are asso-
ciated even with the ‘isolated’ “non-syndromic” variety of BA, can introduce trait heterogeneity
in any test cohort. Unrecognized disease trait heterogeneity is a common cause of failure to
replicate an association [17]. These limitations in determining BA pathogenesis with GWAS
studies are well served by the availability of a well-characterized zebrafish model of bile duct
development. This model can provide supportive evidence for additional novel susceptibility
genes also identified by GWAS.
To identify additional susceptibility loci we performed GWAS in Caucasian BA cases and
controls who presented to the Children’s Hospital of Pittsburgh (CHP) and the Center for
Applied Genomics (CAG) at the Children’s Hospital of Philadelphia. This analysis identified
ARF6 as a leading candidate gene involved in bile duct development, based on SNP associa-
tions. To identify other ARF6-related pathways members, the top-ranked SNPs identified by
GWAS were further evaluated with a systems biology analysis. Similar to previous GWAS stud-
ies, we used MO-mediated translation blockade to obtain supportive evidence for the role of
arf6 in the early bile duct development in zebrafish.
Materials and Methods
Children with BA were enrolled at CHP after obtaining written consent from parents for the
University of Pittsburgh IRB approved protocol number 0405628. At CAG, all subjects were
enrolled after obtaining written consent from parents per Children’s Hospital of Philadelphia
IRB approval number 06–004886. Genotyping of DNA obtained from blood was performed
with the Infinium HumanHap550K BeadChip (Illumina, San Diego, CA). SNP genotype fre-
quencies were compared between cases and controls with a chi-square test statistic applied in
Plink [18] for SNPs with at least 90% call rate and 1% minor allele frequency (MAF). Fourteen
additional patients were genotyped with TaqMan1 SNP Genotyping Assay (Life Technologies
ID; C_11918520_10) for the candidate SNP; rs3126184. Taqman genotyping assay was not
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available for rs10140366. All zebrafish experiments were performed with approval from the
Institutional Animal Care and Use Committee (IACUC) of the University of Pittsburgh,
approval number 13102738.
ARF6 immunostaining of liver explants from children with BA
Formalin fixed, paraffin embedded (FFPE) sections were stained on the Ventana Benchmark
Ultra IHC staining platform using ARF6 polyclonal antibody (Abcam, Cambridge, MA). Anti-
gen retrieval was performed using Ventana’s proprietary ultraCC1 cell conditioning reagent
and visualized with the uvDAB detection system. Sections were counterstained with
hematoxylin.
SNP and Pathway Analysis
Among top-ranked SNP loci, we examined enrichment for other genes related to ARF6 and its
associated EGFR pathway genes [19,20,21]. Network and enrichment analyses using Cytos-
cape, a popular network visualization and analysis tool, and Ingenuity Pathway Analysis (IPA)
were performed [22,23]. First, a large human network was created in Cytoscape by integrating
protein-protein interaction data from BIOGRID and STRING databases, transcription factor
interaction from TRANSFAC, and pathway information from KEGG pathways [24,25,26,27].
From the STRING database that uses a scoring scheme between 0 and 1 based on predicted
and experimentally validated protein-protein interactions, a 0.9 cutoff was used to extract
highly probable protein-protein interaction. Then, a smaller network was created using only
the first neighbors of genes that could be mapped from the top 1000 significant SNPs from the
GWAS CHP cohort. For SNP-to-gene mapping, +/- 20kb window was applied on the mapping
file provided by the manufacturer for the Infinium HumanHap550K BeadChip (Illumina, San
Diego, CA). A total of 2506 genes in the new local network was submitted to Ingenuity Path-
way Analysis (IPA) for upstream regulator analysis and enrichment of canonical pathways and
biological functional categories.
Zebrafish strains
Embryos and adult fish were raised and maintained under standard laboratory conditions. We
used the following transgenic lines: Tg(EPV.Tp1-Mmu.Hbb:EGFP)um14 [28], Tg(EPV.
Tp1-Mmu.Hbb:hist2h2l-mCherry)s93 [29], Tg(fabp10a:dsRed;ela3l:EGFP)gz [30], [referred to
here as Tg(Tp1:GFP), Tg(Tp1:H2B-mCherry), and Tg(fabp10a:dsRed), respectively], Tg(ins:
dsRed)m1018 [31], and Tg(sox17:GFP)s870 [32].
Morpholino, mRNA, and DNA injections
Embryos were injected at the one—cell stage with 0.5 or 2 ng of arf6-ATGMO (5’-GATCTTG
GAAAGCATCTTCCCCATG-3’) [33], 3 ng of arf6a-UTR MO (5’-GTGCAAGACTTAGTCGCT
TTTCCGA-3’) or 3 ng of arf6b-UTR MO (5’-GTTCATAAATGGTCAATTCCCT CCA-3’).
120 pg of arf6amRNA or 25 pg of plasmids containing CMV:GFP constructs was injected into
the cell at the one-cell stage.
Chemical treatment
A 3.17 mM stock of the EGFR inhibitor AG1478 (Cayman Chemical) was prepared in 100%
dimethyl sulfoxide (DMSO) and diluted to 1 or 4 μMwith egg water. As a control, 0.1% DMSO
solution in egg water was used.
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Whole-mount in situ hybridization and immunostaining
Whole-mount in situ hybridization was performed as previously described [34]. Whole-mount
immunostaining was performed as previously described [35], using the following antibodies:
anti-GFP (1:1000; Aves Labs, Inc., Tigard, OR), anti-Prox1 (1:1000; Millipore, Billerica, MA),
mouse monoclonal 2F11 (1:100; Abcam, Cambridge, MA), anti-Abcb11 (1:200; Kamiya Bio-
medical, Seattle, WA), anti-dsRed (1:200; Clontech, Mountain View, CA), anti-Arf6 (1:400;
Abcam, Cambridge, MA), anti-β-catenin (1:200; Sigma-Aldrich, St. Louis, MO) and Alexa
Fluor 488-, 568-, and 647-conjugated secondary antibodies (1:500; Life Technologies, Grand
Island, NY). Hoechst 33342 (2.5 ng/ml; Sigma-Aldrich, St. Louis, MO) was used for DNA
staining.
Time-lapse imaging
Time-lapse imaging was performed as previously described [36]. Briefly, Tg(Tp1:GFP);Tg(Tp1:
H2B-mCherry) larvae at 74 hpf were partially mounted on 0.5% low-melting agarose in a 35
mm petri dish containing egg water supplemented with 0.2 mM 1-phenyl-2-thiourea (Sigma-
Aldrich) and 2 μg/ml tricaine (Sigma-Aldrich). Confocal Z-stack images were captured every
15 minutes for 10 hours using a 20x water dipping lens.
PED-6 and proliferation assay
PED-6 assay was performed by treating larvae with 0.3 μg/ml PED-6 (Life Technologies) for 3
hours as described previously [37]. Proliferation assay was performed by treating larvae with
egg water containing 10 mM EdU (Life Technologies) and 1% DMSO. After one-hour EdU
treatment, the larvae were harvested and processed for EdU labeling using the Click-it EdU
Imaging kit (Life Technology).
Generation of GFP expression constructs for morpholino validation
The GFP coding region was amplified by PCR with a forward primer that contains a morpho-
lino target sequence in front of GFP start codon and a reverse primer that contains its stop
codon. The PCR products were cloned into the pGEM-T vector (Promega, Madison, WI) and
their sequences were analyzed. Clones without any mutations were chosen and used for sub-
cloning into the pCS2+ expression vector that contains the CMV promoter and the SV40
polyA site. Plasmids containing the final CMV: GFP constructs were used for injection.
qRT-PCRmethods
Total RNA was extracted from pool of 100 livers of uninjected control and arf6-ATGMO-
injected larvae at 4.5 dpf by using RNeasy Mini Kit (Qiagen, Valencia, CA). Whole transcrip-
tome amplification system (WTA2) (Sigma Aldrich, St. Louis, MO) was used to synthesize μg
quantities of amplified cDNA starting with ~ 50 ng of total RNA. Quantitative PCR was mea-
sured in SYBR Green/ROX qPCR master mix (Fermentas, Glen Burnie, MD) with primers
(IDT, Coralville, IA) shown in S1 Table. qPCR was performed using 7300 Real Time PCR
(Applied Biosystems, Foster City, CA). The relative expression level of genes was shown in fold
change as normalized to the house keeping gene, eef1a1l1 by using the Ct method.
Image acquisition, processing, and statistical analysis
Zeiss LSM700 confocal and Leica M205 FA epifluorescence microscopes were used to obtain
zebrafish image data. Confocal stacks were analyzed using the Zen 2009 software. The length
of BEC filopodia and interconnecting bile preductules was measured using the ImageJ software
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and was shown as means ± SEM (standard error of the mean). The number of BECs was also
counted using the ImageJ software as previously described [38]. Unpaired two-tailed Student’s
t-test was used for statistical analysis; p<0.05 was considered statistically significant.
Results
GWAS identifies ARF6 as a BA susceptibility locus
All DNA samples had excellent data quality with call rates>98%. Of 50 CHP and 30 CAG BA
cases and 2818 controls, 39 CHP and 24 CAG cases, and 1907 controls clustered together on
principal component analysis of>550000 SNPs, and demonstrated a very low genomic infla-
tion factor of 1.00627 (Fig 1A) [39]. In comparison of CHP cases with controls, the 1,000 most
significant SNPs were ranked further by their proximity to other significant SNPs in the top
1000 in 10 kb windows, to boost confidence in the association (S2 Table). rs3126184 and
rs10140366, which ranked 7th and 8th overall in significance emerged as the top-ranked pair
demonstrating significantly higher MAFs in CHP cases, in CAG cases, and 63 combined cases
from both centers, compared with controls (Table 1). Fourteen additional BA cases genotyped
at rs3126184 demonstrated MAF 0.286, and enhanced the significance of the association fur-
ther, when added to 63 cases above (p = 4.19 x10-8, OR = 2.66). rs3126184 and rs10140366
map to 14q22.1 at positions 49442285–49445256 in linkage disequilibrium with each other and
the 8.763 kb upstream gene, ARF6 (Fig 1B). ARF6 regulates embryonic liver development in
mice [40]. ARF6 expression is negatively correlated with the minor alleles of rs1040366 (r =
-0.1346, p = 0.023) and rs3126184 (r = -0.1128, p = 0.061) in the combined HapMap popula-
tions from SNPexp v1.2 [41]. Together, these findings suggest that ARF6 protein expression
may be impaired in BA liver tissue.
GWAS pathway analyses further support the importance of ARF6 and
EGFR signaling
Among the 14 SNPs that fall into the coding region of genes, two mapped to the genes,
CREB3L4 and CRTC2. These genes are related to cAMP response element-binding protein
(CREB) pathway, which can be activated by EGFR signaling through the ERK/MAPK pathway
[42,43,44,45]. We also performed network and enrichment analyses using Cytoscape and Inge-
nuity IPA SNP-to-gene mapping in 20kb+/- windows revealed 299 unique genes associated
with 419 of the 1000 to-ranked SNPs (S2 Table). Ingenuity’s upstream regulator analysis on the
2506 genes (S3 Table) from the first-neighbor network created in Cytoscape revealed that out
of 632 potential upstream regulators, the 35th ranked regulator, sorted by enrichment p-value,
was EGF (p = 1.26 x10-7). Other significant EGF-related upstream regulators were TNF
(p = 3.14 x10-25) and ERK1/2 (p = 3x10-14). The significant canonical pathways were ERK/
MAPK (p = 5.74 x10-37) and cAMP-mediated signaling (p = 1.5 x10-35) pathways while
enriched functional categories were cellular proliferation (p = 1.85 x10-103) and cellular devel-
opment (p = 1.63 x10-46).
Poor ARF6 staining in human BA liver explants with intrahepatic bile
duct paucity
Explants from 29 of 39 CHP cases were immunostained for ARF6 with positive and negative
controls. Hepatocytes and bile ducts showed fine granular immunostaining in normal liver tis-
sue (Fig 1Ci). Poor ARF6 staining was seen in two explants with bile duct paucity with minimal
fibrosis (Fig 1Cii). In one of these explants, paucity was confined to the left lobe. The right lobe
of this and the remaining 27 explants with diffuse ductal hyperplasia, cholestasis, and fibrosis,
ARF6, Biliary Dysgenesis and Biliary Atresia
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demonstrated ARF6 staining which was similar to normal liver tissue (Fig 1Ciii). Intense stain-
ing was observed in hepatocellular carcinoma (positive control, Fig 1Civ). Therefore, ARF6
protein expression was impaired in the presence of bile duct paucity.
The zebrafish orthologues of human ARF6, arf6a, and arf6b are
expressed in the developing liver and endoderm-derived organs
Two arf6 genes, arf6a and arf6b, with identical amino acid sequences, are located on chromo-
somes 20 and 17, respectively, in zebrafish; their amino acid sequences are 99 percent identical
to human ARF6. Using an in situ probe for the arf6a coding region whose nucleotide sequence
is 81% identical to that of arf6b (S1 Fig, black box), we found that arf6a/b expression appeared
ubiquitous at 30 hours post-fertilization (hpf), when the liver-forming region consists of hepa-
toblasts, but is restricted to the liver at 42 hpf, when hepatoblasts differentiate to biliary epithe-
lial cells (BECs) [46] (Fig 2A, arrows). As embryos further develop, arf6a/b expression was
clearly observed in the liver and other endoderm-derived organs including the pancreas and
the intestinal bulb (Fig 2A). We used arf6a and arf6b in situ probes targeting non-identical
3’UTR regions of these genes to determine their relative liver expression (S1 Fig, green and red
boxes, respectively). Both genes were similarly expressed in the liver and other endoderm-
Fig 1. Eigenstrat Principal Components Analysis. (A) Boxed region shows well stratified cases and
controls carried forward in analysis. (B) The BA susceptibility locus defined by rs3126184 and rs10140366
lies in an enhancer region in the 3’ flanking region of the ARF6 gene (UCSC genome browser evaluation
show enriched histone marks H3K4me1 overlayed with H3K27Ac is an indicative of enhancer region). (C) i-iv
show ARF6 immunostaining in liver explants from normal children with intact bile ducts (BD) (i), children with
BA with bile duct paucity in portal tracts (PT) (ii) or cirrhosis (iii), and a child with hepatocellular carcinoma (iv).
T = tumor cells, L = lobule.
doi:10.1371/journal.pone.0138381.g001
Table 1. Association testing results for rs3126184 and rs10140366 for 77 BA cases and 1907 controls.
rs3126184 rs10140366
MAF *p-value OR MAF *p-value OR
Controls (n = 1907) 0.1308 0.1306
CHP BA (n = 39) 0.2821 1.03 x10-4 2.61 0.2821 9.92 x10-5 2.62
CAG BA (n = 24) 0.2917 1.10 x10-3 2.74 0.2917 1.10 x10-3 2.74
CHP&CAG BA (n = 63) 0.2857 5.94 x10-7 2.66 0.2857 5.57 x10-7 2.66
CHP BA (n = 14) 0.2857 1.58 x10-2 2.66
ALL BA (n = 77) 0.2857 4.19 x10-8 2.66
*p-value of MAF comparison of the cases to that of the controls.
doi:10.1371/journal.pone.0138381.t001
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derived organs at 72 hpf (Fig 2B). At 96 hpf, arf6b expression persisted whereas arf6a expres-
sion declined in the liver (Fig 2B).
arf6 knockdown results in biliary defects
To investigate the role of both genes in liver development, we designed three translation-block-
ing antisense morpholino oligonucleotides (MO). arf6a-UTR and arf6b-UTR MOs targeted
Fig 2. arf6 knockdown results in developmental biliary defects in zebrafish. (A, B) Whole-mount in situ hybridization showing arf6a and arf6b
expression in developing embryos/larvae. Arrows point to the liver; arrowheads the pancreas; brackets mark the intestinal bulb. (C) The Tg(Tp1:GFP) and Tg
(fabp10a:dsRed) lines reveal the intrahepatic biliary structure and liver size, respectively. Epifluorescence images showing the expression of these
transgenes revealed a defect in the intrahepatic biliary structure in arf6-ATGMO-injected larvae. Based on the severity of the biliary defect, larvae were
divided into three groups: normal, intermediate, and severe. Graph shows the percentage of larvae in each group. Arrows point to the liver; dotted lines
outline the liver (A-C). (D) Epifluorescence images showing PED-6 accumulation in the gallbladder (arrows). Based on PED-6 levels in the gallbladder, larvae
were divided into three groups: absent, small/faint, and normal. Graph shows the percentage of larvae in each group. n, the number of larvae examined;
scale bars, 100 μm.
doi:10.1371/journal.pone.0138381.g002
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non-identical 5’UTR sequences of corresponding genes; arf6-ATGMO targeted the arf6a ATG
start codon region which demonstrated high sequence homology with the start codon for arf6b
(S1 Fig, underlines). Their efficacy was evaluated by examining green fluorescent protein
(GFP) expression from the CMV:GFP constructs containing each MO-target sequence in front
of the GFP start codon (S2 Fig). The arf6-ATGMO blocked GFP expression from the CMV:
GFP construct containing the corresponding arf6a or arf6b sequences (S2B Fig) because of
high sequence homology in the start codon regions of these two genes, and was therefore used
to knock down both genes. The arf6-ATGMO was further validated by whole-mount immu-
nostaining with anti-Arf6 antibody. Arf6 expression was greatly reduced in the MO-injected
embryos and increased in arf6amRNA-injected embryos (S3 Fig). The Tg(Tp1:GFP)um14 line,
which expresses GFP in BEC [46,38], and the Tg(fabp10a:dsRed)gz15 line, which expresses
dsRed in hepatocytes [47], were used to evaluate intrahepatic biliary structures and liver size,
respectively. Liver size was smaller and importantly intrahepatic biliary ducts were relatively
sparse in arf6-ATGMO-injected larvae, compared with controls (Fig 2C). These phenotypes
were rescued with arf6amRNA in a significant number of larvae (S4A Fig). We next examined
whether hepatocyte secretion into bile ducts was defective in arf6-ATGMO-injected larvae
using the fluorescently labeled fatty acid reporter PED-6, which accumulates in the gallbladder
after biliary secretion [37]. PED-6 accumulation in the gallbladder was greatly reduced in the
MO-injected larvae compared to controls (Fig 2D). This defect was rescued with arf6amRNA
in a significant number of larvae (S4B Fig). Single injection of arf6a- or arf6b-UTR MO pro-
duced biliary defects in a smaller number of larvae than co-injections of these two UTRMOs,
or injection with arf6-ATGMO (S5 Fig), indicating that both arf6a and arf6b regulate biliary
development.
Detailed characterization of biliary developmental defects was performed at multiple stages
from 40 hpf to 5 days post-fertilization (dpf) using whole-mount immunostaining and confocal
microscopy. Compared with controls, arf6-ATGMO-injected embryos/larvae demonstrated 1)
smaller liver size, as assessed by the expression of the hepatoblast marker Prox1 [48] or the
hepatocyte marker fabp10a:dsRed (Fig 3A), 2) reduced number of BECs, as assessed by Tp1:
GFP expression, with reduced dispersion and enhanced clustering (Fig 3A), 3) reduced filopo-
dial protrusion of BECs at 72 and 96, but not 62, hpf in fixed larvae (Fig 3B) and from 74 to 84
hpf in live larvae (S6 Fig), 4) reduced length of interconnecting bile preductules at 5 dpf, as rep-
resented by the distance between two nuclei of BECs (Fig 3C). In particular, although liver size
in the MO-injected embryos at 62 hpf was similar to that in controls at 48 hpf, their BEC distri-
bution was very different from each other, suggesting that the biliary defects observed in the
MO-injected embryos were not simply due to developmental delay. We further confirmed the
clustering phenotype, using the Tg(Tp1:H2B-mCherry)s939 line that expresses mCherry in BEC
nuclei [38]. The quantification of the percentage of single BECs versus cells in cluster of two,
three, or four and more cells revealed a significant decrease in the percentage of BECs present
as single cells and doublets in the MO-injected larvae compared to controls, concomitant with
a significant increase in the percentage of cells in clusters of four and more cells (Fig 3D). This
clustering phenotype was not due to increased BEC proliferation. In a proliferation assay, the
rate of BEC proliferation was not significantly different between controls and the MO-injected
larvae at 75 hpf (S7C Fig), although the total number of BECs in each liver was smaller in the
MO-injected larvae than in controls (S7B Fig). Since bile first secretes into bile canaliculi that
connect bile preductules in zebrafish and bile ductules in mammals, we also examined the
expression patterns of Abcb11, a bile salt export pump present in the bile canaliculi of hepato-
cytes [49]. The canaliculi were much shorter in the MO-injected larvae than in controls (Fig
3E).
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Fig 3. arf6 regulates intrahepatic biliary morphogenesis. (A-C) Confocal images showing the development of the intrahepatic biliary network. Tg(Tp1:
GFP) embryos/larvae were processed for immunostaining with anti-GFP (green). For 40 and 48 hpf, anti-Prox1 staining (red) was also used. Brackets
delineate the length of BEC filopodia at 62, 72, and 96 hpf, and the length of interconnecting bile preductules at 5 dpf (A); graphs show their quantitation (B,
C). (D) Confocal images showing the location of BEC nuclei in the entire liver. The Tg(Tp1:H2B-mCherry) line reveals BEC nuclei. Dashed lines outline
clusters with four or more BECs. Graph shows the percentage of BECs present as single cells, doublets, triplets, or in clusters of four or more cells. (E)
Confocal images of the liver immunostained for GFP (green) and Abcb11 (red). The Tg(Tp1:GFP) line and anti-Abcb11 reveal the intrahepatic biliary structure
and bile canaliculi, respectively. All dotted lines outline the liver. Asterisks, statistical significance (* p<0.0001); error bars, ± SEM; scale bars, 25 μm.
doi:10.1371/journal.pone.0138381.g003
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arf6 knockdown results in defects in other endoderm-derived organs
Since arf6a and arf6b are also expressed in other endoderm-derived organs (Fig 2B), we inves-
tigated whether other endoderm-derived organs are defective in arf6-ATGMO-injected
embryos using the Tg(sox17:GFP)s870 line that expresses GFP in all endodermal cells [32]. The
pancreas and the intestinal bulb were smaller in the MO-injected embryos than in controls
(S8A Fig, arrowheads and brackets, respectively). In addition, the budding of the swim bladder,
the zebrafish equivalent of the mammalian lung, was not evident in the MO-injected embryos
at 48 hpf, whereas it was evident in controls (S8A Fig, open arrowhead). In contrast to these
defects, the gallbladder, EHBD, and the extrapancreatic duct appeared normal in the MO-
injected larvae at 75 hpf (S8B Fig), as assessed by the 2F11 antibody, which targets the hepato-
pancreatic ductal system [35].
Blocking EGFR signaling results in biliary defects
Because EGFR signaling activates ARF6 and induces breast cancer invasion, we tested whether
impaired EGFR signaling could reproduce the intrahepatic biliary defects observed in arf6-
ATGMO-injected larvae [50]. The expression of egfra, a zebrafish orthologue of human EGFR,
was clearly observed in the liver at 72 hpf (Fig 4A). Compared with DMSO-treated controls,
larvae treated with 4 μMAG1478, a potent EGFR inhibitor [51], from 48 hpf onwards demon-
strated 1) reduced BEC filopodial length (Fig 4B), bile canaliculi length (Fig 4C), and PED-6
accumulation in the gallbladder (Fig 4E), 2) enhanced clustering of BECs (Fig 4D) without dif-
ferences in proliferation at 75 hpf (S7C Fig). Therefore, EGFR-Arf6 signaling pathway may reg-
ulate intrahepatic biliary morphogenesis.
We next investigated whether EGFR signaling and Arf6 acted in the same pathway to regu-
late intrahepatic biliary morphogenesis. At four-fold lower doses (0.5 ng and 1 μM, respec-
tively), arf6-ATGMO or AG1478 alone produced minimal or no defects in intrahepatic biliary
structure at 75 hpf or in PED-6 accumulation in the gallbladder at 5 dpf. When these two
reagents were combined, biliary structure was greatly affected (Fig 5A and 5B) and PED-6
accumulation greatly reduced (Fig 5C), similar to embryos injected with 2 ng of arf6-ATGMO
(Fig 2C and 2D). These data suggest that EGFR and Arf6 likely regulate intrahepatic biliary
morphogenesis via the same pathway.
EGFR-GEP100-ARF6 pathway genes are upregulated in arf6MO-
injected larvae
We next examined, by quantitative PCR, the expression levels of EGFR-GEP100-ARF6 path-
way genes. ARF6 is necessary for membrane pseudopod formation via ASAP1 [52] and RAC1
and also activates ERK/MAPK signaling via RAC1 [53, 54], We also examined the expression
of hedgehog signaling genes which were upregulated in zebrafish embryos after knockdown of
gpc1 in a previous study [13].
Dissected liver tissue from 4.5-dpf zebrafish larvae, injected with arf6-ATGMO in three
batches of ~100 larvae each, showed that egfra, gep100, arf6, asap1 and rac1 were upregulated
in all replicates in arf6morphants compared with uninjected embryos (Fig 6). Among the
hedgehog signaling genes, only ptch1, but not gli1 or gli2a demonstrated consistent upregula-
tion in all three replicates (S4 Table). The transcription factors, gli1, and gli2amediate the
effects of the hedgehog receptor ptch1 on downstream genes in the canonical hehdgehog sig-
naling pathway. These observations suggested that arf6 knockdown affects EGFR, but not
canonical hedgehog signaling in the liver.
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Discussion
Our study identifies the chromosome 14q21.3 locus, defined by the highly associated SNPs
rs3126184 and rs10140366, as a susceptibility locus for BA. This 3’ flanking region includes the
upstream ARF6 gene, because minor alleles at both SNP loci are associated with decreased
ARF6 expression in the combined HapMap populations (SNPexp v1.2), and rs10140366 lies in
Fig 4. EGFR signaling regulates biliary morphogenesis. (A) Whole-mount in situ hybridization image showing egfra expression in the liver at 72 hpf. (B)
Confocal images of the liver showing the intrahepatic biliary structure, as revealed by Tp1:GFP expression. Tg(Tp1:GFP) embryos were treated with DMSO
or 4 μMAG1478 from 48 to 96 hpf, and processed for whole-mount immunostaining with anti-GFP antibody. The length of BEC filopodia was quantified as
shown in a graph. Brackets delineate the length of BEC filopodia. (C) Confocal images of the liver showing the expression of Tp1:GFP (green) and Abcb11
(red) for biliary structure and bile canaliculi, respectively. (D) Confocal images of the liver showing the location of BEC nuclei in the entire liver, as assessed
by Tp1:H2B-mCherry expression. Dashed lines outline clusters with four or more BECs. Graph showing the percentage of BECs present as single cells,
doublets, triplets, or in clusters of four or more cells. (E) Epifluorescence images showing PED-6 accumulation in the gallbladder in DMSO- or
AG1478-treated larvae at 5 dpf. Graph showing the percentage of larvae exhibiting different levels of PED-6 accumulation in the gallbladder. Arrows point to
the gallbladder. All dotted lines outline the liver. n indicates the number of larvae examined; asterisks indicate statistical significance (* p<0.0001). Error bars,
± SEM; scale bars, 25 μm.
doi:10.1371/journal.pone.0138381.g004
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an enhancer region enriched for the histone marks H3K4me1 and H3K27Ac (Fig 1B). Further,
Arf6-/- knockout mice show impaired liver development [40]. Although distinct from GPC1
and ADD3, two genes associated with BA in recent GWAS, the ARF6 gene has similar func-
tional and developmental consequences [13,16]. Knockdown of both gpc1 and arf6 in zebrafish
impairs biliary network formation. This is expected because GPC1 and ARF6 mediate fibro-
blast and epidermal growth factor signaling, respectively, which are necessary for the growth
and development of organs by epithelial branching morphogenesis [55,56]. ADD3 may also
have a developmental role because it is expressed to a greater extent in fetal liver than in adult
liver [57]. ARF6 and ADD3 both regulate actin cytoskeletal remodeling, and affect cell mobility
and cell-cell contact, which facilitate organogenesis [52,58]. Among the top-ranked 1000 SNPs
in our study, rs17127145 closest to the ADD3 gene ranked 676th; none was in proximity to the
glypican-1 gene. Therefore, the association between bile duct paucity and poor ARF6 immu-
nostaining in explants with BA led us to further ask whether arf6 knockdown in zebrafish
could affect early biliary morphogenesis and explain the clinical manifestations of BA.
Fig 5. EGFR signaling and Arf6 act in the same pathway in the regulation of intrahepatic biliary morphogenesis. Instead of 4 μMAG1478 and 2 ng of
arf6-ATGMO, 1 μMAG1478 and 0.5 ng of arf6-ATGMOwere used. (A) Epifluorescence images showing the expression of Tp1:GFP and fabp10a:dsRed
revealed a severe defect in the intrahepatic biliary structure only when the MO injection was combined with the AG1478 treatment. Based on the severity of
the biliary defect, larvae were divided into three groups: normal, intermediate, and severe. Arrows point to the liver and dotted lines outline the liver. Scale
bars, 100 μm. (B) Graph showing the percentage of larvae in each group shown in A. (C) Graph showing the percentage of larvae exhibiting different levels of
PED-6 accumulation in the gallbladder at 5 dpf. n indicates the number of larvae examined.
doi:10.1371/journal.pone.0138381.g005
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Poor intrahepatic biliary network formation and poor bile excretion manifested as absence
of PED-6 accumulation in the gallbladder are dominant effects of arf6 knockdown. Clinical
correlates include failure to excrete radionuclide into the extrahepatic bile duct on hepatobili-
ary scanning, failure of surgical drainage, and bile duct paucity in some BA patients [59,60]. In
arf6-ATGMO-injected zebrafish embryos, poor bile excretion also results from reduced biliary
canalicular length and enhanced clustering of BEC, presumably due to reduced BEC mobility
during morphogenesis. Altered epithelial cell polarity is a known effect of ARF6 deficiency in
MDK canine kidney cell line [61]. Clinical correlates include canalicular dilatation with cystic
bile lakes characteristic of the “ductal plate malformation” in up to a fourth of BA patients
[62]. Because MO is diluted out by cell division, arf6MO effects are short-lived. arf6mutant
lines are needed to investigate long-term consequences. Other pathways may also function at
subsequent developmental stages and explain why EHBD loss and atretic gallbladders charac-
teristic of human BA were absent in arf6MO-injected zebrafish.
ARF6 is a critical member of the EGFR pathway, which facilitates organ development,
growth and regeneration by regulating epithelial branching morphogenesis [56]. ARF6 is acti-
vated by the binding of EGFR to its activator, GEP100 and has several downstream effects.
Activation of the downstream effector ASAP1 is necessary for a normal actin cytoskeleton and
cell membrane function [52]. An upregulated EGFR-GEP100-ARF6 pathway facilitates inva-
dopodia formation in invasive breast cancer. ARF6 is also required for RAC1-mediated epithe-
lial cell polarity [61] and membrane pseudopod formation [53]. RAC1 activation also regulates
ERK signaling [54]. Sequential activation of ERK/MAPK and CREB signaling pathways is
required for normal cellular development and proliferation, and is another downstream effect
of EGFR-GEP100-ARF6 signaling [43,44,45,52]. Systems biology analysis of GWAS results
supports the role of this molecular pathway in BA by showing enrichment of EGF regulatory
genes, the canonical ERK/MAPK and CREB signaling pathways, and the functional categories
of cellular development and proliferation (Fig 7).
Therefore, we hypothesized further and found that EGFR signaling blockade with the inhib-
itor AG1478 reproduced all biliary defects associated with arf6-ATGMO-induced knockdown
in zebrafish. Further, reduced doses of AG1478 and arf6-ATGMO also reproduced these
Fig 6. Quantitative RT-PCR analysis of EGFR pathway genes in liver tissue from zebrafish. The relative expression level of genes was shown in fold
change in arf6morphants over un-injected controls. Error bars shown, ± SEM (average of three independent experiments).
doi:10.1371/journal.pone.0138381.g006
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defects when used in combination, but not when used alone. These observations suggest that
EGFR-ARF6 signaling regulates early branching morphogenesis of the biliary tree, and that
functionally impaired pathway members could also contribute to poor bile drainage likely
from abnormal intrahepatic biliary network in children with BA. Supportive evidence consists
of poor ARF6 immunostaining in those liver explants, which manifested bile duct paucity with-
out fibrosis, but not in the remainder, in which advanced cirrhosis with marked cholestasis pre-
cluded an evaluation of intrahepatic bile ducts prior to the development of chronic obstructive
changes (Fig 1C).
The complex molecular effects of arf6 knockdown in zebrafish also provide potential expla-
nations for the fibrosis that is seen in BA. arf6 knockdown in zebrafish was associated with
intrahepatic upregulation of egfra, gep100, arf6, and genes for downstream effectors of Arf6
such as asap1 and rac1 (Fig 6). Among the canonical hedgehog signaling pathway genes, which
have been implicated previously in biliary dysgenesis only ptch1, which induces several hedge-
hog target genes via effects on the gli family of receptors, and not the gli1 or gli2 genes, was con-
sistently upregulated in arf6morphants (S4 Table) (13). Activation of Erk by sonic hedgehog
can occur independent of canonical hedgehog signaling via PTCH [63] further confirming that
ARF6 dysregulation may have several downstream effects on cell membrane function, cell pro-
liferation and cell development via effects on downstream effectors, ASAP1, RAC1 and
PTCH1. In experimental models, upregulated EGFR pathway members lead to fibrosis and cir-
rhosis, a common finding at liver transplantation after failed portoenterostomy for BA [64].
These observations from an established zebrafish model of bile duct development provide
additional supportive evidence for the biological relevance of ARF6 in biliary atresia in this
first report. Obvious future directions also include replication of these experimental findings.
This task requires that the effects of an induced perturbation be observed over several days in
Fig 7. A proposedmechanism for poor bile duct development in BA. Ligation of activated EGFR to
GEP100 initiates sequential activation of ARF6, ERK/MAPK and CREB signaling proteins resulting in cellular
development and proliferation. Negative regulation of ARF6 originating from the regulatory regions defined by
rs3126184 and rs10140366 in human BA, and arf6 knockdown or EGFR inhibition with AG1478 in zebrafish
embryos lead to poor bile duct development.
doi:10.1371/journal.pone.0138381.g007
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invitro mammalian cell lines, because complete disruption of the ARF6 gene in Arf6 -/- mice
leads to almost complete lethality [40]. Because previous studies conducted in patients with BA
indicate a high likelihood of multiple susceptibility loci and the environment in disease patho-
genesis, future models, which cannot demonstrate such additive effects are likely to maintain a
supportive role placing the larger burden of proof back on the human evidence from diseased
subjects.
It is generally assumed that the intrahepatic biliary tree is also abnormal in extrahepatic atre-
sia [65,59,60]. However, intrahepatic ducts cannot be examined before the onset of jaundice and
clinical evidence of extrahepatic obstruction in human BA. Anecdotally, serial biopsies from
four children with confirmed extrahepatic biliary atresia have demonstrated that intrahepatic
bile duct paucity without fibrosis preceded obstructive ductal proliferation and cirrhosis at por-
toenterostomy or liver transplantation [66]. Features indicative of intrahepatic duct involvement
are predominantly clinical; disease progression despite portoenterostomy, an attenuated intra-
hepatic picture on cholangiography; and histopathologic—lymphocytes around and within
intrahepatic BECs [67,68]. In the Rhesus rotavirus mouse model of BA, intrahepatic portal areas
may contain lymphocytes though the relevance of the model to human BA is unclear [11,69].
Also not evident is whether intrahepatic changes in human BA are primary, or secondary to
extrahepatic obstruction. Landing, in 1974, proposed a unitarian hypothesis of infantile obstruc-
tive cholangiopathies in which the entire biliary tree was vulnerable but extrahepatic or intrahe-
patic disease depended on the developmental timing and nature of the insult [70]. The concept
lapsed for lack of proof until now. The zebrafish model from two independent studies, including
ours, suggests again that the entire biliary tree is genetically susceptible and that in this instance,
the outcome of ARF6 dysregulation involves the intrahepatic tree.
In summary, GWAS studies and analysis of SNP data for functions and pathways postulates
the role of ARF6, involved in the EGFR pathway, in defective bile duct formation. We validate
this hypothesis in a zebrafish model, which unambiguously shows that arf6 knockdown
impacted the EGFR pathway in the liver and lead to defective bile duct formation.
Supporting Information
S1 Fig. Sequence alignment between arf6a and arf6b cDNA. Sequences chosen for the design
of arf6-ATG, arf6a-UTR, and arf6b-UTR MOs are underlined black, green, and red, respec-
tively. The target regions of arf6, arf6a, and arf6b in situ probes are boxed black, green, and
red, respectively. The start (ATG) and stop (TAA) codons of these two genes are red colored.
(TIF)
S2 Fig. Morpholino validation. (A-D) CMV:GFP constructs containing the target sequence of
each MO in front of the GFP start codon were injected alone or together with the correspond-
ing MO. GFP expression was barely detected in the co-injected embryos. Graphs show the per-
centage of embryos exhibiting strong, weak, or no GFP expression. arf6-ATGMO also blocked
GFP expression from the CMV:GFP constructs containing the arf6b region corresponding to
the MO target region in arf6a (B), indicating that arf6-ATGMO blocks both arf6a and arf6b
translation. n indicates the number of embryos examined. Scale bars: 200 μm.
(TIF)
S3 Fig. Arf6 expression is greatly reduced in arf6-ATGMO-injected embryos.Wild-type
embryos were injected at the one-cell stage with 2 ng of arf6-ATGMO or 120 pg of arf6a
mRNA, harvested at 7 hpf, and processed for whole-mount immunostaining with anti-Arf6
(green) and anti-β-catenin (red) antibodies. DNA was also stained with Hoechst 33342 (gray).
β-catenin expression reveals the cell membrane. Confocal images showed that Arf6 expression
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was greatly increased in arf6amRNA-injected embryos, whereas it was greatly reduced in arf6-
ATGMO-injected embryos, validating the efficacy of the MO. Dorsal views; scale bar, 25 μm.
(TIF)
S4 Fig. arf6amRNA injection partially rescues biliary defects in arf6-ATGMO-injected lar-
vae. (A) The Tg(Tp1:GFP), Tg(fabp10a:dsRed), and Tg(ins:dsRed) lines were used to reveal the
intrahepatic biliary structure, the liver, and the dorsal pancreas, respectively. Epifluorescence
images showing the expression of these transgenes revealed that a defect in the intrahepatic bil-
iary structure in arf6-ATGMO-injected larvae was partially rescued by arf6amRNA injection.
Based on the severity of the biliary defect, larvae were divided into three groups: normal, inter-
mediate, and severe. Graph showing the percentage of larvae in each group. Arrows point to
the liver; arrowheads point to the dorsal pancreas. Dotted lines outline the liver. Lateral views,
anterior to the left. (B) Epifluorescence images showing PED-6 accumulation in the gallbladder
revealed that the PED-6 accumulation defect in arf6-ATGMO-injected larvae was also par-
tially rescued by arf6amRNA injection. Based on PED-6 levels in the gallbladder, larvae were
divided into three groups: absent, small/faint, and normal. Graph showing the percentage of
larvae in each group. Arrows point to the gallbladder. Lateral views, anterior to the right. n
indicates the number of larvae examined. Scale bars, 100 μm.
(TIF)
S5 Fig. Simultaneous knockdown of arf6a and arf6b results in more severe biliary defects
than their single knockdown. (A) The Tg(Tp1:GFP), Tg(fabp10a:dsRed), and Tg(ins:dsRed)
lines were used to reveal the intrahepatic biliary structure, the liver, and the dorsal pancreas,
respectively. Epifluorescence images showing the expression of these transgenes revealed that a
severe biliary defect was observed more often in larvae co-injected with 3 ng of arf6a-UTR and
3 ng of arf6b-UTR MOs than in singly injected larvae. Based on the severity of the biliary
defect, larvae were divided into three groups: normal, intermediate, and severe. Graph showing
the percentage of larvae in each group. Arrows point to the liver; arrowheads point to the dor-
sal pancreas. Dotted lines outline the liver. Lateral views, anterior to the left. (B) Epifluores-
cence images showing PED-6 accumulation in the gallbladder. Based on PED-6 levels in the
gallbladder, larvae were divided into three groups: absent, small/faint, and normal. Graph
showing the percentage of larvae in each group. Arrows point to the gallbladder. Lateral views,
anterior to the right. n indicates the number of larvae examined. Scale bars, 100 μm.
(TIF)
S6 Fig. The movement of BEC filopodia is greatly reduced in arf6-ATGMO-injected larvae.
(A, B). Time-lapse confocal images showing BEC behaviors in arf6-ATGMO-injected and
control larvae. The behaviors were assessed by Tp1:GFP (green) and Tp1:H2B-mCherry (red)
expression in BEC cytoplasm and nuclei, respectively. Confocal images every 60 minutes from
74 to 84 hpf were presented. Arrows point to BEC filopodia. Scale bars, 25 μm.
(TIF)
S7 Fig. Proliferation is not affected in arf6-ATGMO-injected or AG1478-treated larvae at
75 hpf. (A) Confocal images showing EdU+ proliferating cells (gray) and H2B-mCherry+ BECs
(red) in the liver of control, arf6-ATGMO-injected, or AG1478-treated Tg(Tp1:H2B-mCherry)
larvae. For EdU labeling, the larvae were treated with EdU for one hour prior to harvest. Dotted
lines outline the liver. Scale bar, 50 μm. (B) Graph showing the total number of BECs in each
liver. Asterisks indicate statistical significance:  p<0.0001,  p<0.005. (C) Graph showing the
percentage of EdU+ BECs among BECs. Error bars, ± SEM. n indicates the number of larvae
examined.
(TIF)
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S8 Fig. The effect of arf6 knockdown on the development of endoderm-derived organs. (A)
Confocal images showing the endoderm and endoderm-derived organs at 48 hpf. The Tg
(sox17:GFP) line was used to reveal the endoderm and endoderm-derived organs. Arrows,
arrowheads, and open arrowhead point to the liver, the pancreas and the swim bladder, respec-
tively; brackets mark the intestinal bulb. (B) Confocal images showing the hepatopancreatic
ductal system at 75 hpf. Tg(Tp1:GFP);Tg(fabp10a:dsRed) larvae were processed for whole-
mount immunostaining with 2F11 (gray), GFP (green), and dsRed (red) antibodies. In contrast
to the intrahepatic biliary defect, the hepatopancreatic ductal system, revealed by 2F11 anti-
body, appeared to be normal in arf6-ATGMO-injected larvae. Arrows, arrowheads, open
arrowheads, and open arrows point to the gallbladder (gb), the extrahepatic duct (ehd), the
common bile duct (cbd), and the extrapancreatic duct (epd), respectively. The hepatopancrea-
tic ductal system is schematically illustrated. Ventral views, anterior up. Scale bars, 50 μm.
(TIF)
S1 Table. qPCR primer sequences for gene expression studies in liver tissue from zebrafish.
(DOCX)
S2 Table. Four hundred nineteen SNPs mapped to unique 299 genes within 20kb+/- win-
dows among the top 1000 significant SNPs in CHP cohort with BA in the genome wide
association study.
(XLS)
S3 Table. Among the 1000 top-ranked significant SNPs, 419 mapped to 299 unique genes
as described in the methods. Among these genes, 231 showed interaction with other genes
from the large human network consisting mainly of protein-protein interaction. The first
neighbor network was created by assimilating all of the first interacting genes with these 231
genes from the large human network. The total of 2506 genes in the new smaller network is
listed in the table. More information can be found in the table that includes the average P-val-
ues calculated from multiples SNPs and the interacting genes.
(XLSX)
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